Effect of treatment variation on outcomes in patients with clostridium difficile

American Journal of Medicine

Volumn 127, Issue 9, 2014, Pages 865-870

  Brown, Adam T ^a   Seifert, Charles F ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Clostridium difficile; Infectious diarrhea; Treatment guidelines

Indexed keywords

CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; METRONIDAZOLE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DEATH; FEMALE; HOSPITAL BED CAPACITY; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NONHUMAN; PATIENT REFERRAL; PRACTICE GUIDELINE; RECURRENT INFECTION; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TERTIARY HEALTH CARE; TOXIC MEGACOLON; TREATMENT OUTCOME; ADOLESCENT; CLOSTRIDIUM INFECTION; COMPARATIVE STUDY; DIARRHEA; DRUG ADMINISTRATION; EVALUATION STUDY; INFECTIOUS DIARRHEA; INTRAVENOUS ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; STATISTICAL MODEL; TREATMENT GUIDELINES; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

CLOSTRIDIUM DIFFICILE; INFECTIOUS DIARRHEA; TREATMENT GUIDELINES;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; DRUG ADMINISTRATION SCHEDULE; FEMALE; GUIDELINE ADHERENCE; HUMANS; LOGISTIC MODELS; MALE; MEGACOLON, TOXIC; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; RETROSPECTIVE STUDIES; TEXAS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908161271     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.05.016     Document Type: Article

References (15)

1. C.P. Kelly, and J.T. LaMont Clostridium difficile - more difficult than ever N Engl J Med 359 18 2008 1932 1940
2. E. Bouza Consequences of Clostridium difficile infection: understanding the healthcare burden Clin Microbiol Infect 18 6 2012 5 12
3. M.D. Zilberberg, A.F. Shorr, and M.H. Kollef Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005 Emerg Infect Dis 14 6 2008 929 931
4. Steiner C, Barrett M, Terrel L. HCUP Projections: Clostridium Difficile Hospitalizations 2011 to 2012. 2012. HCUP Projections Report # 2012-01. Online July 10, 2012. U.S. Agency for Healthcare Research and Quality. Available at: http://www.hcupus.ahrq.gov/reports/projections/2012-01.pdf. Accessed November 22, 2013.
5. C. Wenisch, B. Parschalk, M. Hasenhündl, A.M. Hirschl, and W. Graninger Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea Clin Infect Dis 22 5 1996 813 818
6. Recommendations for Preventing the Spread of Vancomycin Resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC) MMWR Morb Mortal Wkly Rep 44 RR-12 1995 1 13
7. D.M. Musher, S. Aslam, and N. Logan Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole Clin Infect Dis 40 11 2005 1586 1590
8. J. Pepin, M.E. Alary, and L. Valiquette Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada Clin Infect Dis 40 11 2005 1591 1597
9. F.A. Zar, S.R. Bakkanagari, K.M. Moorthi, and M.B. Davis A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity Clin Infect Dis 45 3 2007 302 307
10. S.H. Cohen, D.N. Gerding, and S. Johnson Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA) Infect Control Hosp Epidemiol 31 5 2010 431 455
11. C.M. Surawicz, L.J. Brandt, and D.G. Binion Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections Am J Gastroenterol 108 2013 478 498
12. th revision. Available at: http://www.cms.gov/medicare-coverage-database/staticpages/icd-9-code-lookup.aspx. Accessed November 1, 2011.
13. C.G. Jardin, H.R. Palmer, and D.N. Shah Assessment of treatment patterns and patient outcomes before vs. after implementation of severity based Clostridium difficile infection treatment policy J Hosp Inf 85 2013 28 32
14. E.A. McGlynn, S.M. Asch, and J. Adams The quality of health care delivered to adults in the United States N Engl J Med 348 26 2003 2635 2645
15. Centers for Disease Control and Prevention (CDC) Vital signs: preventing Clostridium difficile infections MMWR Morb Mortal Wkly Rep 61 2012 157 162